Anacin
- Product NDC
- 63736-200
- Requested package NDC
- 63736-200-95
- 11-digit product format
- 637360200
- Labeler code
- 63736
- Product ID
- 63736-200_4895609d-1ec8-4ebd-8b6e-61ccd452ad5b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Asprin and Caffeine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Insight Pharmaceuticals LLC
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2009-06-25
- Substance
- ASPIRIN; CAFFEINE
- Active strength
- 400; 32 mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 63736-200 | 63736-200-95 | D | Discontinued by firm | 2026-11-19 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Anacin
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ASPIRIN | 400 mg/1 |
| CAFFEINE | 32 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| R16CO5Y76E | Internal UNII lookup |
| 3G6A5W338E | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63736-200-04 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-04 | Anacin | 4 in 1 BLISTER PACK | TABLET | 4 | 9 | |
| 63736-200-30 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-30 | Anacin | 30 in 1 BOTTLE | TABLET | 30 | 9 | |
| 63736-200-50 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-50 | Anacin | 50 in 1 BOTTLE | TABLET | 50 | 9 | |
| 63736-200-90 | Anacin | 100 in 1 BOTTLE | TABLET | 100 | 9 | |
| 63736-200-90 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-91 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-91 | Anacin | 130 in 1 BOTTLE | TABLET | 130 | 9 | |
| 63736-200-92 | Anacin | 125 in 1 BOX | TABLET | 125 | 9 | |
| 63736-200-92 | Anacin | 1 in 1 POUCH | TABLET | 1 | 9 | |
| 63736-200-93 | Anacin | 300 in 1 BOTTLE | TABLET | 300 | 9 | |
| 63736-200-93 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-95 | Anacin | 750 in 1 BOX | TABLET | 750 | 9 | |
| 63736-200-95 | Anacin | 1 in 1 POUCH | TABLET | 1 | 9 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Aspirin | ACTIVE INGREDIENT | R16CO5Y76E | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| Caffeine | ACTIVE INGREDIENT | 3G6A5W338E | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| Aspirin | ACTIVE MOIETY | R16CO5Y76E | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| Caffeine | ACTIVE MOIETY | 3G6A5W338E | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| sodium lauryl sulfate | INACTIVE INGREDIENT | 368GB5141J | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Childrens Chewables | ACETAMINOPHEN | Strategic Sourcing Services LLC | af2cbbaf-9b73-440a-bc88-a790cafccc6b | 2026-10-28 | Warnings | M013 |
| Aspirin | ASPIRIN | Walgreen Company | 82cc404b-fcf5-4e48-ab1a-09d8c47f9e04 | 2026-10-27 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | REMEDYREPACK INC. | 05618d62-ebec-4d30-989d-999891977e0e | 2026-10-27 | Warnings | M013 |
| Tension Headache Relief | ACETAMINOPHEN AND CAFFEINE | HHH Pharmaceuticals | 0ba50950-2e6e-4337-a776-b19ac988feca | 2026-10-27 | Warnings | M013 |
| ASPIRIN | ASPIRIN | Marc Glassman, Inc. | 14cb1d2d-95b8-447e-8d79-e6ec82c0e431 | 2026-10-27 | Warnings | M013 |
| GoodMeds Acetaminophen Rapid Release | ACETAMINOPHEN RAPID RELEASE | Cabinet Health P.B.C. | 5ed756b6-dbab-e742-e063-6294a90a27f3 | 2026-10-27 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | PD-Rx Pharmaceuticals, Inc. | da7d95af-6583-429d-8d04-e0424f32e9ad | 2026-10-27 | Warnings | M013 |
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | WALGREENS | 07d34e7a-c0c6-f3c4-e063-6294a90aa5c3 | 2026-10-26 | Warnings | M013 |
| Aspirin | ASPIRIN | Marlex Pharmaceuticals Inc. | cc7013ea-cf30-6f59-e053-2a95a90a1148 | 2026-10-26 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | PD-Rx Pharmaceuticals, Inc. | 3f96aeb1-a533-4d36-9a1f-62fc094b6754 | 2026-10-26 | Warnings | M013 |
| Acetaminophen PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | FOODHOLD U.S.A., LLC | fdd7ce80-d6be-41b9-affd-d024cf306b50 | 2026-10-26 | Warnings | M013 |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | CVS Pharmacy | 9e459853-5951-4ae7-88a6-85b502e9dd41 | 2026-10-26 | Warnings | M013 |
| Bayer Genuine Aspirin | ASPIRIN | Select Consumer Group | 3ca776c2-47ed-5107-e063-6394a90ac5df | 2026-10-24 | Warnings | M013 |
| Excedrin Extra Strength Headache | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | Select Consumer Group | 3caa0a47-de83-90d2-e063-6394a90a3436 | 2026-10-24 | Warnings | M013 |
| Aspi-Cor | ASPIRIN | L.N.K. International, Inc. | 9f919a48-ffd8-49fa-b6fd-ec71cc12e64b | 2026-10-23 | Warnings | M013 |
| Aspirin Enteric Coated, Regular Strength | ASPIRIN | Walgreen Company | 5e1484d3-5be1-40da-a3bf-fb19f7d27d45 | 2026-10-23 | Warnings | M013 |
| MAX relief junior Grape | CHILDRENS ACETAMINOPHEN | Atlantic Biologicals Corp. | 5e38af7c-f5f3-6e5c-e063-6294a90a1772 | 2026-10-23 | Warnings | M013 |
| Acetaminophen Extra Strength | ACETAMINOPHEN | CVS PHARMACY | 64a1ebe7-af28-4b09-96e8-28fa4dcc52bd | 2026-10-23 | Warnings | M013 |
| Genexa Kids Pain and Fever | ACETAMINOPHEN | Genexa Inc. | 5130c695-a80e-2dd3-e063-6294a90a404f | 2026-10-22 | Warnings | M013 |
| Tension Headache Relief | ACETAMINOPHEN, CAFFEINE | Pioneer Life Sciences, LLC | ac9efd62-8fee-b777-e053-2995a90a3783 | 2026-10-21 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 211292 | ANACIN 400 MG / 32 MG Oral Tablet | PSN | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 198479 | aspirin 400 MG / caffeine 32 MG Oral Tablet | PSN | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 211292 | aspirin 400 MG / caffeine 32 MG Oral Tablet [Anacin] | SBD | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 198479 | aspirin 400 MG / caffeine 32 MG Oral Tablet | SCD | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 211292 | Anacin (ASA 400 MG / caffeine 32 MG) Oral Tablet | SY | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 198479 | ASA 400 MG / Caffeine 32 MG Oral Tablet | SY | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 211292 | ASA 400 MG / Caffeine 32 MG Oral Tablet [Anacin] | SY | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63736-200-95 | 63736020095 | 750 POUCH in 1 BOX (63736-200-95) > 1 TABLET in 1 POUCH | 750 pouch | 2009-06-25 | 2023-06-30 | No | No | Current |